File JWaters MD 5-30-12 Presentation

download File JWaters MD 5-30-12 Presentation

of 50

Transcript of File JWaters MD 5-30-12 Presentation

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    1/50

    Changing Landscape of Obstetrical

    Hemorrhage

    Jonathan H. Waters, MD

    Professor of Anesthesiology and Bioengineering

    Chief of Anesthesiology, Magee-Womens Hospital of University ofPittsburgh Medical Center

    Medical Director, UPMC Total Blood Management Program

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    2/50

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    3/50

    http://bloodjournal.hematologylibrary.org/content/112/7/2617/F5.large.jpg

    Blundells Blood Gravitator

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    4/50

    Is obstetrical hemorrhage a

    problem worth addressing?

    A. Mortality

    B. Morbidity

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    5/50

    Healthy People, 2010

    www.cdc.gov

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    6/50

    The Joint Commission Sentinel

    Event Alert

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    7/50

    Pregnancy-related deaths in the United States in 20062007

    http://www.cdc.gov/reproductivehealth/MaternalInfantHealth/Pregnancy-relatedMortality.htm

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    8/50

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    9/50

    Morbidity of Hemorrhage

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    10/50

    Postpartum hemorrhage

    associated morbidity

    Disseminated intravascular coagulopathy (DIC)

    Renal and hepatic failure

    Acute respiratory distress syndrome

    Sheehans Syndrome

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    11/50

    Postpartum hemorrhage

    associated morbidity

    Iron deficiency

    Iron deficiency anemia

    Transfusion

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    12/50

    Bodnar LM et al. Am J Obstet & Gynecol 2005;193:36-44

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    13/50

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    14/50

    Complications of Transfusions

    I. Infectious Complications VII. Delayed TransfusionReactions

    II. Hemolytic TransfusionReactions

    VIII. NonhemolyticTransfusion Reactions

    III. Immunomodulation IX. Graft-vs-host Disease

    IV. Storage Defects X. Febrile Reactions

    V. Cost XI. Allergic Reactions

    VI. Gene Transmission XII. HLA Sensitization

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    15/50http://www.cmqcc.org/resources/1484

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    16/50

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    17/50http://www.cmqcc.org/resources/1484

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    18/50

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    19/50

    POSTPARTUM HEMORRHAGE PROTOCOL

    Strategy for Managing PPH Anticipation

    Identification of Risk Factors

    Prevention / Preparation

    Recognition Assessment

    Accurate Estimation of Blood Loss

    Identification of Cause Act

    Postpartum Hemorrhage Protocol (PPHP)

    Mobilization of Rapid Response Team

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    20/50

    Admission Hemorrhage Risk FactorsLow (Type & Screen/Hgb) Medium (Type & Screen/Hgb) High (Type & Cross/CBC with

    Plt)

    No previous uterine incision Prior Cesarean birth(s) oruterine surgery (RR = 10.38)

    Placenta previa, Low lyingplacenta (RR = 3.38)

    Singleton Pregnancy (RR =

    60.69)

    > 5 previous vaginal births Suspected placenta accreta or

    percreta

    5 previous vaginal births Chorioamnionitis (RR = 2.56) Hgb < 10 and other risk factors

    No known bleeding disorder History of PPH Active bleeding on admission

    No history of PPH Large uterine fibroids Known coagulopathy (RR =

    2.97)

    Hypertensive disorder of

    pregnancy (RR = 2.05)

    Retained placenta

    Overdistended uterus

    (macrosomia, polyhydramnios,

    etc) (RR = 1.63)

    Uterine rupture

    Obesity (RR = 1.43) Hgb < 8

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    21/50

    POSTPARTUM HEMORRHAGE PROTOCOL

    Strategy for Managing PPH

    Anticipation Identification of Risk Factors

    Prevention / Preparation Recognition

    Assessment

    Accurate Estimation of Blood Loss

    Identification of Cause Act

    Postpartum Hemorrhage Protocol (PPHP)

    Mobilization of Rapid Response Team

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    22/50

    POSTPARTUM HEMORRHAGE PROTOCOL

    Assessment

    Ongoing quantitative evaluation of blood loss

    Peach pad Plaid cloth pad Blue Chux pad

    250 mL loss 100 mL loss 150 mL loss

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    23/50

    POSTPARTUM HEMORRHAGE PROTOCOL

    Strategy for Managing PPH

    Anticipation Identification of Risk Factors

    Prevention / Preparation Recognition

    Assessment

    Accurate Estimation of Blood Loss

    Identification of Cause Act

    Postpartum Hemorrhage Protocol (PPHP)

    Mobilization of Rapid Response Team

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    24/50

    Obstetric Crisis Patient Safety

    Initiative: Magee-Womens Hospital

    Medical Emergency Team Paradigm applied toobstetric care

    Condition O

    Assemble necessary personnel with singlepage

    Force interdisciplinary communication

    Encourage early crisis recognition Encourage teamwork

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    25/50

    Wiser

    Obstetric Crisis Team Training Course

    Course Format:

    Web-based presentation

    Pre-course survey

    Pretest

    Brief didactic session

    3 full scale human simulation scenarios

    Video-based debriefing

    Post-course survey

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    26/50

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    27/50

    Staff in room informed of bleeding? Anesthesia aware? Intra-op consultsneeded/requested?

    Call for help: OR charge (1-2802), Generalist (1-2526), Triage (1-2679), MFM (2862),Anesthesia (1-4148 ), Gyn Onc (med-trak), Urogyn (Medtrak)

    Initial resuscitation: IV access x2? IVF open with pressure bag? Cell saver on thefield? Warming patient?

    Source of bleeding?

    -Is the uterus atonic?-Are all uterotonics in the room (see chart)?

    -Recheck uterus for retained tissue?

    -Is the uterine incision (including angles) hemostatic? -Apex of extension visualized and hemostatic?

    -Is a vaginal/cervical exam warranted?

    -Bakri balloon? Compression sutures?

    -Is a hysterectomy being considered? Is a hysterectomy tray in the room?

    -Any concern for bladder/ureteral injury? Cysto available?

    Assessment of hemorrhage:-Stat CBC, platelets, INR, fibrinogen drawn and sent? Are serial labs needed? TEG performed?

    -EBL and pt hemodynamics discussed?

    -Has the blood bank (4646) been notified? Massive transfusion protocol activated?

    Recovery:Does this patient need an ICU bed? Has CCM been notified (1-2790)?

    C-Section Hemorrhage

    Triggers for

    checklist

    use:

    -EBL

    >1000cc

    - A bleedingextension

    identified

    - Surgeon

    calls for

    uterotonics

    Objective: Stop bleeding, maintain

    hemodynamic stability, avoid coagulopathy

    Call ADM

    charge

    Picklephone

    1-2800

    Anesthesia Hemorrhage Checklist

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    28/50

    Call for help if major fluid resuscitation necessary

    Reduce volatile agents and nitrous oxide if hypotensive

    Maintain normothermia with a fluid warmer and forced air warming blanketConsider rapid transfusion device

    Consider blood salvage device (COBE BRAT)

    Ensure adequate IV access, consider CVP, surgical cannulation of abdominal vein if abdomen

    open.

    Consider aortic cross-clamping.

    Consider Vigileo, arterial line and CVP for hemodynamic monitoring

    Consider TEE for continued hypotensionMonitor hemoglobin, TEG, electrolytes, ABG at frequent intervals

    Remember to normalize any hypocalcemia with supplemental CaCl2at 500-1000 mg doses

    Maintain acid base status with volume resuscitation and NaHCO3

    Consider Tranexamic Acid, 1 gm IV for continued bleeding and suspected fibrinolysis

    Consider trauma pack or major transfusion protocol.

    Consider interosseus drill if IV access problematic

    Trauma Pack = 10 units of RBCs (uncross-matched Group O) available in 5 minutes

    FFP is NOT included but the Transfusion Service Staff will ask if FFP is needed.

    Massive Transfusion Protocol (RBC + PLASMA + PLTS)

    Anesthesia Hemorrhage Checklist

    Anesthesia Hemorrhage Checklist

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    29/50

    Call for help if major fluid resuscitation necessary

    Reduce volatile agents and nitrous oxide if hypotensive

    Maintain normothermia with a fluid warmer and forced air warming blanketConsider rapid transfusion device

    Consider blood salvage device (COBE BRAT)

    Ensure adequate IV access, consider CVP, surgical cannulation of abdominal vein if abdomen

    open.

    Consider aortic cross-clamping.

    Consider Vigileo, arterial line and CVP for hemodynamic monitoring

    Consider TEE for continued hypotensionMonitor hemoglobin, TEG, electrolytes, ABG at frequent intervals

    Remember to normalize any hypocalcemia with supplemental CaCl2at 500-1000 mg doses

    Maintain acid base status with volume resuscitation and NaHCO3

    Consider Tranexamic Acid, 1 gm IV for continued bleeding and suspected fibrinolysis

    Consider trauma pack or major transfusion protocol.

    Consider interosseus drill if IV access problematic

    Trauma Pack = 10 units of RBCs (uncross-matched Group O) available in 5 minutes

    FFP is NOT included but the Transfusion Service Staff will ask if FFP is needed.

    Massive Transfusion Protocol (RBC + PLASMA + PLTS)

    Anesthesia Hemorrhage Checklist

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    30/50

    B tl A t t f i S t

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    31/50

    Duncan SE et al. Ann Surg 1974;180:296-304

    Bentley Autotransfusion System

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    32/50

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    33/50

    Catling S, Joels L. IJOA 2005;112:131-2

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    34/50

    Organizations recommending blood

    salvage during the peripartum period

    Confidential Enquiry into Maternal and Child

    Health (UK) National Institute for Health and Clinical

    Excellence (UK)

    Obstetric Anesthetists Association (UK) Assoc. of Anaesthetists of Great Britain and

    Ireland (UK)

    Anesthesia Hemorrhage Checklist

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    35/50

    Call for help if major fluid resuscitation necessary

    Reduce volatile agents and nitrous oxide if hypotensive

    Maintain normothermia with a fluid warmer and forced air warming blanketConsider rapid transfusion device

    Consider blood salvage device (COBE BRAT)

    Ensure adequate IV access, consider CVP, surgical cannulation of abdominal vein if

    abdomen open.

    Consider aortic cross-clamping.

    Consider Vigileo, arterial line and CVP for hemodynamic monitoring

    Consider TEE for continued hypotensionMonitor hemoglobin, TEG, electrolytes, ABG at frequent intervals

    Remember to normalize any hypocalcemia with supplemental CaCl2at 500-1000 mg doses

    Maintain acid base status with volume resuscitation and NaHCO3

    Consider Tranexamic Acid, 1 gm IV for continued bleeding and suspected fibrinolysis

    Consider trauma pack or major transfusion protocol.

    Consider interosseus drill if IV access problematic

    Trauma Pack = 10 units of RBCs (uncross-matched Group O) available in 5 minutes

    FFP is NOT included but the Transfusion Service Staff will ask if FFP is needed.

    Massive Transfusion Protocol (RBC + PLASMA + PLTS)

    Anesthesia Hemorrhage Checklist

    Interosseus Drill

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    36/50

    Interosseus Drill

    Anesthesia Hemorrhage Checklist

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    37/50

    Call for help if major fluid resuscitation necessary

    Reduce volatile agents and nitrous oxide if hypotensive

    Maintain normothermia with a fluid warmer and forced air warming blanketConsider rapid transfusion device

    Consider blood salvage device (COBE BRAT)

    Ensure adequate IV access, consider CVP, surgical cannulation of abdominal vein if abdomen

    open.

    Consider aortic cross-clamping.

    Consider Vigileo, arterial line and CVP for hemodynamic monitoring

    Consider TEE for continued hypotensionMonitor hemoglobin, TEG, electrolytes, ABG at frequent intervals

    Remember to normalize any hypocalcemia with supplemental CaCl2at 500-1000 mg doses

    Maintain acid base status with volume resuscitation and NaHCO3

    Consider Tranexamic Acid, 1 gm IV for continued bleeding and suspected fibrinolysis

    Consider trauma pack or major transfusion protocol.

    Consider interosseus drill if IV access problematic

    Trauma Pack = 10 units of RBCs (uncross-matched Group O) available in 5 minutes

    FFP is NOT included but the Transfusion Service Staff will ask if FFP is needed.

    Massive Transfusion Protocol (RBC + PLASMA + PLTS)

    Anesthesia Hemorrhage Checklist

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    38/50

    Vigileo Flo-trac

    LiDCO

    Non-invasive Cardiac Output Monitors

    Anesthesia Hemorrhage Checklist

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    39/50

    Call for help if major fluid resuscitation necessary

    Reduce volatile agents and nitrous oxide if hypotensive

    Maintain normothermiawith a fluid warmer and forced air warming blanketConsider rapid transfusion device

    Consider blood salvage device (COBE BRAT)

    Ensure adequate IV access, consider CVP, surgical cannulation of abdominal vein if abdomen

    open.

    Consider aortic cross-clamping.

    Consider Vigileo, arterial line and CVP for hemodynamic monitoring

    Consider TEE for continued hypotensionMonitor hemoglobin, TEG, electrolytes, ABG at frequent intervals

    Remember to normalize any hypocalcemia with supplemental CaCl2at 500-1000 mg doses

    Maintain acid base status with volume resuscitation and NaHCO3

    Consider Tranexamic Acid, 1 gm IV for continued bleeding and suspected fibrinolysis

    Consider trauma pack or major transfusion protocol.

    Consider interosseus drill if IV access problematic

    Trauma Pack = 10 units of RBCs (uncross-matched Group O) available in 5 minutes

    FFP is NOT included but the Transfusion Service Staff will ask if FFP is needed.

    Massive Transfusion Protocol (RBC + PLASMA + PLTS)

    Anesthesia Hemorrhage Checklist

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    40/50

    Body Temperature ( C)

    Effect of Body Temperature on Coagulation

    Rohrer MJ, Natale AM. Crit Care Med1992;20:1402-5.

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    41/50

    Meng et al. J. Trauma 2003;55:886

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    42/50

    Probability of Life-Threatening Coagulopathy

    increases wi th hypo tension and hypotherm ia

    Clinical Status Conditional Probability ofdeveloping coagulopathy

    No risk Factor 1%

    Severe trauma>25 10%Severe trauma+ISS*Systolic BP

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    43/50

    Point of Care Testing

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    44/50

    Point of Care Testing

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    45/50

    Near Care Testing

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    46/50

    Nuttall GA et al. Anesthesiology 2001;94:773-81

    Outcome with Algorithm and Point of care testing

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    47/50

    Nuttall GA et al. Anesthesiology 2001;94:773-81

    Outcome with Algorithm and Point of care testing

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    48/50

    Process Measure

    Obstetrical and Anesthesia Hemorrhage Checklist

    Nominator: Checklist Use

    Denominator: Number of OB hemorrhages

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    49/50

    Outcome MeasurePercent of women transfused

    The goal would be to reduce the percentage of womentransfused.

    Numerator: Women who gave birth >=20 weeks gestation

    and received 1 unit or > units of any blood product during

    Denominator: All births

    Average transfusion exposureThis would measure whether QI has reduced transfusion

    exposure. This is important because the complications of

    transfusion are dose related.

    Numerator: total units transfused

    Denominator: women transfused

  • 7/26/2019 File JWaters MD 5-30-12 Presentation

    50/50

    Questions?

    Jonathan Waters, M.D.

    [email protected]